What the pediatric nurse needs to know about the Impella cardiac assist device.
Giorgia BorrelliIlaria NittoloChiara BochicchioLaura TrainelliValerio ConfaloneTiziana SattaFederica CancaniRichard KirkAntonio AmodeoMatteo Di NardoPublished in: Perfusion (2024)
Background: Cardiogenic shock in children still carries a high mortality risk despite advances in medical therapy. The use of temporary mechanical circulatory supports is an accepted strategy to bridge patients with acute heart failure to recovery, decision, transplantation or destination therapy. These devices are however limited in children and extracorporeal membrane oxygenation (ECMO) remains the most commonly used device. Veno-arterial ECMO may provide adequate oxygen delivery, but it does not significantly unload the left ventricle, and this may prevent recovery. To improve the likelihood of left ventricular recovery and minimize the invasiveness of mechanical support, the Impella axial pump has been increasingly used in children with acute heart failure in the last decade. Purpose: There are still limited data describing the Impella indications, management and outcomes in children, therefore, we aimed to provide a comprehensive narrative review useful for the pediatric nurses to be adequately trained and acquire specific competencies in Impella management.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- acute heart failure
- left ventricular
- respiratory failure
- young adults
- heart failure
- healthcare
- mechanical ventilation
- type diabetes
- mitral valve
- stem cells
- metabolic syndrome
- pulmonary hypertension
- public health
- cell therapy
- intensive care unit
- adipose tissue
- coronary artery
- pulmonary artery
- decision making
- skeletal muscle
- acute coronary syndrome
- resistance training
- high intensity